Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
E15
Hong KongPre-Seed–Late Stage
1 person
EQx Fund
BostonPre-Seed–Late Stage
1 person
NJF Capital
LondonSeed–Late Stage
1 person
Pura Vida Investments
New YorkLate Stage
Borealis Ventures
HanoverPre-Seed–Late Stage
1 person
Fjord Ventures
Laguna HillsSeed–Late Stage
1 person
Nesta Ventures
LondonSeed–Late Stage
1 person
TriWise Capital
ShenzhenPre-Seed–Late Stage
1 person
XSeed Capital
Menlo ParkPre-Seed–Late Stage
6 people
East West Capital Limited
SydneyPre-Seed–Late Stage
1 person
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Late Stage
1 person
Panda Capital
Pre-Seed–Late Stage
1 person
ward.ventures
Prairie VillageSeed–Late Stage
1 person
RUSNANO
MoscowSeed–Late Stage
Stonebridge Ventures
SeoulSeed–Late Stage$743K – $33M
3 people
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Avon River Ventures
Seed–Late Stage
1 person
Bija Ventures
AspenGrowth–Late Stage
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.















